Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension

Hypertension is found frequently in patients with COVID-19 and is often treated with ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). SARS-CoV-2, the pathogen of COVID-19, binds to the receptors of ACE2 to enter the alveolar cells, raising questions on whether these drugs are salutar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzeytemiz, Mustafa, Tenekecioglu, Erhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753108/
https://www.ncbi.nlm.nih.gov/pubmed/34987107
http://dx.doi.org/10.1136/jim-2021-002036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753108/
https://www.ncbi.nlm.nih.gov/pubmed/34987107
http://dx.doi.org/10.1136/jim-2021-002036

Ejemplares similares